CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on developing and marketing proprietary, innovative medical therapies to the dermatology market. CollaGenex...
Field emission based flat panel displys are perhaps the closest to realizing the first commercial application of carbon nanotubes. In these devices field emission current can be reduced by using...
http://www.azonano.com/article.aspx?ArticleID=1411 | 6 Oct 2005
Purification of carbon nanotubes (CNTs) generally refers to the separation of CNTs from other entities. Processes such as gas phase, liquid phase and intercalation have been used. These processes are...
http://www.azonano.com/article.aspx?ArticleID=1562 | 17 May 2006
Technologies for producing metal nanopowders and metal nanopoarticles are described. Technologies include triorganohydroborate reduction, reduction of polyols, reduction of alcohols and the...
http://www.azonano.com/article.aspx?ArticleID=1333 | 29 Jul 2005
For any DLS system, its performance is based on the sample, for instance, the upper size limit for a high-density particle may be 5µm for an emulsion because of the possibility of losing analysis...
http://www.azonano.com/article.aspx?ArticleID=4110 | 24 Jul 2015
FSI International, Inc. (Nasdaq: FSII), a leading supplier of surface conditioning equipment for microelectronics manufacturing, announced today that it has received an order for its ORION single...
http://www.azonano.com/news.aspx?newsID=18239 | 25 Jun 2010
a global leader focused on the health and safety of people and the environment,
today announced the addition of the Atomax™ line of 1.5 inch hollow cathode
http://www.azonano.com/news.aspx?newsID=15555 | 21 Jan 2010
In the past decade, Group III-nitride materials have been widely used for
visible and ultraviolet light emitting diodes and blue, violet laser diodes.
Most of these optoelectronic devices are...
http://www.azonano.com/news.aspx?newsID=10330 | 10 Mar 2009
Inc., a privately held specialty biopharmaceutical company, announced that
it has it has submitted an Investigational New Drug (IND) application to the
FDA for a Phase I...
http://www.azonano.com/news.aspx?newsID=10339 | 11 Mar 2009
In this application note, we demonstrate the utility of AFM in delineating the cause of cataracts. High-resolution imaging of native lens membranes and the constitutive protein components was achieved...
http://www.azonano.com/article.aspx?ArticleID=2323 | 22 Jun 2009